<- Go Home

iCAD, Inc.

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.

Market Cap

$41.6M

Volume

165.0K

Cash and Equivalents

$18.8M

EBITDA

-$5.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$16.6M

Profit Margin

87.51%

52 Week High

$2.65

52 Week Low

$1.18

Dividend

N/A

Price / Book Value

1.42

Price / Earnings

-7.85

Price / Tangible Book Value

1.99

Enterprise Value

$23.3M

Enterprise Value / EBITDA

-4.55

Operating Income

-$5.9M

Return on Equity

-17.56%

Return on Assets

-8.95

Cash and Short Term Investments

$18.8M

Debt

$415.0K

Equity

$29.4M

Revenue

$18.9M

Unlevered FCF

-$2.1M

Sector

Health Care Technology

Category

N/A

Company Stock Pitches